Cargando…

IL-1 beta receptor antagonist efficacy in the treatment of idiopathic recurrent pericarditis

Detalles Bibliográficos
Autores principales:	Picco, P, Traverso, F, Brisca, G, Parodi, A, Loy, A, Gattorno, M, Martini, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333922/ http://dx.doi.org/10.1186/1546-0096-6-S1-P126

Ejemplares similares

PReS-FINAL-2333: Long term efficacy of interleukin-1 receptor antagonist (anakinra) in a multicentric cohort of patients affected by idiopathic recurrent pericarditis
por: Finetti, M, et al.
Publicado: (2013)

Etanercept efficacy in the treatment of chronic isolated inflammatory coxitis
por: Parodi, A, et al.
Publicado: (2008)

Long-term efficacy of IL-1 blockers in PAPA patients
por: Finetti, M, et al.
Publicado: (2015)

PW03-018 – Efficacy of Anakinra in recurrent pericarditis
por: Finetti, M, et al.
Publicado: (2013)

Different pattern of synthesis and secretion of IL-1beta in patients with CIAS-1 and TNFRSF1A mutations responding to IL-1 blockade
por: Lasigliè, D, et al.
Publicado: (2008)

A case of corticosteroid-dependent recurrent pericarditis with different response to two IL-1 blocking agents
por: Theodoropoulou, K, et al.
Publicado: (2015)

Long-term follow-up of systemic onset juvenile idiopathic arthritis patients treated with Anakinra
por: Gattorno, Marco, et al.
Publicado: (2011)

The Use of IL-1 Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis: A Narrative Review
por: Baskar, Shankar, et al.
Publicado: (2016)

Long-term efficacy of etanercept in ADA2 deficiency
por: Caorsi, Roberta, et al.
Publicado: (2014)

PReS-FINAL-2237: The diagnostic challenge of osteolytic bone lesions in autoinflammatory diseases: a case report
por: Caorsi, R, et al.
Publicado: (2013)

Juvenile eosinophilic fasciitis: report of three cases with a review of the literature
por: Papa, R, et al.
Publicado: (2015)

Recurrent poliserositis succesfully treated with IL-1 receptor antagonist Anakinra
por: Lovillo, MS Camacho, et al.
Publicado: (2011)

Enlarging the clinical spectrum of SAVI syndrome
por: Caorsi, R, et al.
Publicado: (2015)

Identification of type I interferonopathies using blood interferon signature: the experience of a pediatric rheumatology center
por: Volpi, S, et al.
Publicado: (2015)

PReS-FINAL-2324: PAPA syndrome clinical spectrum and IL-1Β release
por: Omenetti, A, et al.
Publicado: (2013)

A controlled trial of intra-articular corticosteroids with or without methotrexate in oligoarticular juvenile idiopathic arthritis
por: Bracciolini, GP, et al.
Publicado: (2014)

Chronic active EBV infection mimicking periodic fever syndromes: a new challenge for the paediatrician
por: Caorsi, Roberta, et al.
Publicado: (2014)

Comparison of the accuracy of different definitions of clinical remission (CR) and minimal disease activity (MDA) in juvenile idiopathic arthritis (JIA)
por: Davì, S, et al.
Publicado: (2008)

Analysis of ceiling effect and score distribution of outcome measures in juvenile idiopathic arthritis (JIA)
por: Lattanzi, B, et al.
Publicado: (2008)

Idiopathic Recurrent Pericarditis: Not Really So Idiopathic?
por: Roubille, François, et al.
Publicado: (2022)

Interleukin-1 Antagonists for the Treatment of Recurrent Pericarditis
por: Abadie, Bryan Q., et al.
Publicado: (2022)

Development of small-molecule transforming growth factor beta antagonists
por: Warner, DJ, et al.
Publicado: (2006)

Quantitative assessment of synovitis in juvenile idiopathic arthritis using Dynamic Contrast-Enhanced Magnetic Resonance Imaging
por: Malattia, C, et al.
Publicado: (2008)

Evidences for the need of new Diagnostic Criteria for PFAPA syndrome
por: Caorsi, R, et al.
Publicado: (2008)

PReS-FINAL-2240: Serum amyloid protein a concentration in CAPS patients treated with anti IL1Β
por: Pastore, S, et al.
Publicado: (2013)

Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age
por: Roca, Clara Giménez, et al.
Publicado: (2014)

IL-1 receptor antagonist restores IL-18 NK cell axis in systemic JIA
por: Vastert, Sebastiaan J, et al.
Publicado: (2012)

B cell subsets phenotype in autoimmunity with immunodeficiency: analysis of a cohort of patients with APECED syndrome
por: Magnani, A, et al.
Publicado: (2011)

B cells characterization in ADA2 Deficiency patients
por: Schena, F, et al.
Publicado: (2015)

Comparison of physician's, parent's and patient's global ratings made on linear or 21-circle visual analogue scales (VAS) in juvenile idiopathic arthritis (JIA)
por: Dalprà, S, et al.
Publicado: (2008)

The diagnostic role of hyperferritinemia in a tertiary care pediatric rheumatology setting
por: Sala, I, et al.
Publicado: (2008)

Canakinumab treatment shows maintained efficacy in systemic juvenile idiopathic arthritis patients
por: Wulffraat, NM, et al.
Publicado: (2014)

CMR characterization of atrioventricular inflow in constrictive pericarditis - findings of blood impact physiology
por: Angheloiu, George O, et al.
Publicado: (2015)

Efficacy of tonsillectomy in a family with a PFAPA-like phenotype
por: Alpigiani, MG, et al.
Publicado: (2008)

Distinct cerebrovascular features in patients with ADA2 deficiency
por: Severino, MS, et al.
Publicado: (2015)

Value of cardiovascular magnetic resonance in patients with suspected inflammatory pericarditis
por: Cruz, Inês, et al.
Publicado: (2015)

Characterization of B cells in synovial fluid and tissue from patients with JIA
por: Ferlito, F, et al.
Publicado: (2008)

Novel intracellular function of IL-1 receptor antagonist type 1 in endothelial cells
por: Gabay, C, et al.
Publicado: (2003)

Idiopathic Pericarditis
por: Macpherson, R. B.
Publicado: (1884)

Corticosteroids for Acute and Recurrent Idiopathic Pericarditis: Unexpected Evidences
por: Perrone, Antonio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tfphifk3790598id2a5fo412gu